Global contraceptive pills market

Market Dynamics

The pursuit of avoiding unwanted pregnancies and the complications related to it is the prime driver for this market. The product is also used for the treatment of acne, menstrual pain, and bleeding. The support from the government in increasing the awareness level is also driving the growth of the market. Furthermore, it is readily available in the market without the requirement of a doctor's prescription for the purchase.

The major restraints on the market are imposed by the cultural and religious opposition. The lack of knowledge, fear of becoming infertile, and possible side effects are reasons enough for ignoring the product.

The opportunity for the market lies in the issue of increase in population. Furthermore, the modern lifestyle makes people prefer career over their family. This leads to a delay in having children. Investments in research and development will offer innovative and efficient products.

Market Segmentation

The market is segmented in terms of the type of product into progestin-only, combination and others. The market is divided into generic and branded pills on the basis of category. The market can be further segmented on the basis of the region, awareness, and price.

Regional/Geographic Analysis

North America, backed by the government, dominates the market. Asia Pacific offers high growth prospects with increasing awareness, rising disposable income and availability of the product.

Key Players

Some of the major players in the market include Bayer AG, Pfizer, Merck & Co., Reckitt Benckiser Group, Johnson & Johnson, and Lupin Pharmaceuticals.

The report contains comprehensive analysis on:

--> Global Contraceptive Pills Market Segments

--> Global Contraceptive Pills Market Drivers, Restraints and Opportunities

--> Global Contraceptive Pills Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Global Contraceptive Pills Market Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Global Contraceptive Pills Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage